Bowen Hanes & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.71M | Hold |
12,440
| – | – | 0.07% | 84 |
|
|
2026
Q1 | $2.71M | Buy |
12,440
+500
| +4% | +$111K | 0.07% | 84 |
|
|
2025
Q4 | $2.73M | Hold |
11,940
| – | – | 0.07% | 87 |
|
|
2025
Q3 | $2.76M | Sell |
11,940
-2,240
| -16% | -$456K | 0.07% | 89 |
|
|
2025
Q2 | $2.63M | Buy |
14,180
+870
| +7% | +$162K | 0.07% | 87 |
|
|
2025
Q1 | $2.79M | Buy |
13,310
+2,970
| +29% | +$577K | 0.08% | 86 |
|
|
2024
Q4 | $1.84M | Sell |
10,340
-3,295
| -24% | -$606K | 0.05% | 99 |
|
|
2024
Q3 | $2.69M | Buy |
13,635
+3,485
| +34% | +$650K | 0.07% | 86 |
|
|
2024
Q2 | $1.74M | Sell |
10,150
-6,885
| -40% | -$1.14M | 0.05% | 98 |
|
|
2024
Q1 | $3.1M | Buy |
17,035
+13,470
| +378% | +$2.32M | 0.09% | 82 |
|
|
2023
Q4 | $552K | Hold |
3,565
| – | – | 0.02% | 121 |
|
|
2023
Q3 | $531K | Hold |
3,565
| – | – | 0.02% | 117 |
|
|
2023
Q2 | $480K | Sell |
3,565
-35
| -1% | -$5.13K | 0.02% | 125 |
|
|
2023
Q1 | $574K | Buy |
3,600
+870
| +32% | +$133K | 0.02% | 114 |
|
|
2022
Q4 | $441K | Hold |
2,730
| – | – | 0.02% | 124 |
|
|
2022
Q3 | $366K | Hold |
2,730
| – | – | 0.01% | 131 |
|
|
2022
Q2 | $418K | Buy |
2,730
+35
| +1% | +$5.35K | 0.02% | 133 |
|
|
2022
Q1 | $437K | Hold |
2,695
| – | – | 0.01% | 137 |
|
|
2021
Q4 | $365K | Hold |
2,695
| – | – | 0.01% | 139 |
|
|
2021
Q3 | $291K | Buy |
2,695
+480
| +22% | +$54.8K | 0.01% | 146 |
|
|
2021
Q2 | $249K | Hold |
2,215
| – | – | 0.01% | 144 |
|
|
2021
Q1 | $240K | Buy |
+2,215
| New | +$237K | 0.01% | 143 |
|
|
2019
Q2 | – | Sell |
-3,085
| Closed | -$249K | – | 135 |
|
|
2019
Q1 | $249K | Sell |
3,085
-6,400
| -67% | -$524K | 0.01% | 132 |
|
|
2018
Q4 | $874K | Buy |
+9,485
| New | +$834K | 0.04% | 117 |
|
|
2016
Q4 | – | Sell |
-3,580
| Closed | -$226K | – | 135 |
|
|
2016
Q3 | $226K | Buy |
+3,580
| New | +$232K | 0.01% | 129 |
|
|
2016
Q1 | – | Sell |
-4,070
| Closed | -$241K | – | 125 |
|
|
2015
Q4 | $241K | Hold |
4,070
| – | – | 0.01% | 138 |
|
|
2015
Q3 | $221K | Hold |
4,070
| – | – | 0.01% | 139 |
|
|
2015
Q2 | $273K | Buy |
4,070
+250
| +7% | +$16.3K | 0.01% | 138 |
|
|
2015
Q1 | $224K | Hold |
3,820
| – | – | 0.01% | 139 |
|
|
2014
Q4 | $250K | Hold |
3,820
| – | – | 0.01% | 137 |
|
|
2014
Q3 | $221K | Hold |
3,820
| – | – | 0.01% | 144 |
|
|
2014
Q2 | $216K | Buy |
+3,820
| New | +$200K | 0.01% | 133 |
|
|
2014
Q1 | – | Sell |
-4,250
| Closed | -$224K | – | 132 |
|
|
2013
Q4 | $224K | Buy |
+4,250
| New | +$209K | 0.01% | 123 |
|
Other funds holding ABBV
Bowen Hanes & Co's ABBV Position: Q2 2026 in Review
Bowen Hanes & Co held its AbbVie (ABBV) position steady in Q2 2026 at 12,440 shares worth $2.71M. The position accounts for 0.07% of the portfolio, ranked #84.
Bowen Hanes & Co first reported a position in ABBV in Q4 2013 and has held it in 33 quarters since. The position peaked at $3.1M in Q1 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bowen Hanes & Co held 12,440 shares of AbbVie worth $2.71M as of Q2 2026.
- Bowen Hanes & Co left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.07% of Bowen Hanes & Co's portfolio in Q2 2026, its #84 holding.
- Bowen Hanes & Co first reported a position in AbbVie in Q4 2013 and has held it in 33 quarters since.
- Bowen Hanes & Co's AbbVie position peaked at $3.1M in Q1 2024.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bowen Hanes & Co's 13F filing for Q2 2026, filed 13 Aug 2026.